脾氨肽口服冻干粉对小儿支原体感染肺炎伴哮喘临床效果及C反应蛋白的影响

The Clinical Effect and the Influence of CRP of Spleen Peptide Oral Ammonia Producing for Pediatric Pneumonia Mycoplasma Infection Associated with Asthma

目的:研究支原体感染肺炎伴哮喘患儿行脾氨肽口服冻干粉医治对临床效果和C反应蛋白的影响。方法:前瞻性取2015年6月至2016年6月本院收治支原体感染肺炎伴哮喘124例患儿资料进行分析,按不同医治方案分两组,对照组行阿奇霉素抗炎医治,观察组行脾氨肽口服冻干粉医治,比较两组临床效果和C反应蛋白。结果:两组临床效果比较差异显著具统计意义(P<0.05);观察组医治后Ig A、Ig G与T淋巴细胞亚群改善效果均比对照组优,比较差异具有统计学意义(P<0.05),且C反应蛋白、白细胞与肌酐水平均比对照组低,差异具有统计学意义(P<0.05)。结论:支原体感染肺炎伴哮喘患儿行脾氨肽口服冻干粉医治可优化临床效果,降低患儿C反应蛋白水平,值得推广。

Objective： To observe the clinical effect and the influence of c-reactive protein of（ CRP）spleen peptide oral ammonia producing for pediatric pneumonia mycoplasma infection associated with asthma.Methods： The data of 124 children with mycoplasma pneumonia with asthma admitted in our hospital from June 2015 to June 2016 were analyzed. According to the different treatment schemes,all the children were divided into controll group and observe group. The control group were treated with anti-inflammatory treatment with azithromycin,and the observation group were treated with spleen peptide oral ammonia producing. The clinical effects and c-reactive protein（ CRP） expression of two groups were compared. Results： The improving effects of Ig A,Ig G and T lymphocyte subgroup after cure in the observation group were better than that in the control group. The difference was statistically significant（ P 〈 0.05）. The level of CRP,WBC and creatinine in the observation group were lower than the control group（ P 〈0.05）. Conclusion： Mycoplasma pneumonia infection associated with asthma role of spleen peptide oral ammonia producing heal can optimize clinical effect,reduce the children c-reactive protein（ CRP） levels,it is worth promoting.